Charterhouse Capital, Iron Path and Revelar Capital are among the private equity firms building platforms in pain management through platform investments and add-on acquisitions. The trend reflects growing investor confidence in specialized healthcare services that address chronic conditions through minimally invasive approaches.

The US pain management market currently sits at $44.5 billion and is projected to reach $53.6 billion by 2030, according to KPMG data. This represents a compound annual growth rate of 3.1 percent, driven largely by demographic shifts as the population ages and seeks alternatives to traditional opioid treatments.

Investors are responding to increased demand for non-opioid solutions treating back pain, arthritis and neuropathy. These conditions affect millions of Americans, creating a substantial addressable market for PE-backed platforms that can consolidate fragmented providers and scale specialized care delivery.

The influx of private capital signals a maturing market where operational expertise and scale matter more than ever. Firms that can standardize care protocols while maintaining clinical quality will likely capture disproportionate market share as the sector consolidates.